“Real-World Switch Rates of Risankizumab and Other Biologics in Psoriasis Patients With Psoriatic Arthritis”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s443. https://doi.org/10.25251/skin.8.supp.443.